Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi

Microbial Pathogenesis

Volumn 25, Issue 2, 1998, Pages 67-75

  Frisk, A ^a   Ahmed, H J ^a   Van Dyck, E ^b   Lagergard T ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

24 kDA protein; Antibodies; Bactericidal activity; Chancroid; Complement; Haemophilus ducreyi; Lipooligosaccharide

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY; COMPLEMENT; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN;

ANTIBODY BLOOD LEVEL; ARTICLE; BACTERICIDAL ACTIVITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS DUCREYI; HOST RESISTANCE; HUMAN; IMMUNOELECTRON MICROSCOPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULCUS MOLLE;

BACTERIA (MICROORGANISMS); HAEMOPHILUS DUCREYI; HAEMOPHILUS INFLUENZAE; NEGIBACTERIA; ORYCTOLAGUS CUNICULUS;

EID: 0031709077     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0219     Document Type: Article

References (27)

1. Ronald AR, Albritton WL. Chancroid and Haemophilus ducreyi. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, Eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1990: 263-71.
2. Trees DL, Morse SA. Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev 1995; 8: 357-75.
3. Telzak EE, Chiasson, MA, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. HIV-1 seroconversion in patients with and without genital ulcer disease. Ann Intern Med 1993; 199: 1181-6.
4. Taylor PW Bactericidal and bacteriolytic activity of serum against Gram-negative bacteria. Microbiol Rev 1983; 47: 46-83.
5. Joiner KA. Complement evasion by bacteria and parasites. Ann Rev Microbiol 1988; 42: 201-30.
6. Meri S, Pangburn MK. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 1990; 87: 3982-6.
7. Jarvis GA, Vedros NA. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect Immun 1987; 55: 174-80.
8. Edwards MS, Kasper DL, Jennings HJ, Baker CJ, Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol 1982; 128: 1278-83.
9. Van Dijk WC, Verbrugh HA, Van der Toi ME, Peters R, Verhoef J. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Infect Immun 1979; 25: 603-9.
10. Mandrell RE, Kim JJ, Gibson BW, et al. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J Bact 1991; 9: 2823-32.
11. Pilz D, Vocke T, Heesemann J, Brade V. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect Immun 1992; 60: 189-95.
12. Merino S, Alberti S, Tomás JM. Aeromonas salmonicida resistance to complement-mediated killing. Infect Immun 1994; 62: 5483-90.
13. Corbeil LB, Bastida-Corcuera FD, Beveridge TJ. Haemophilus somnus immunoglobulin binding proteins and surface fibrils. Infect Immun 1997; 65: 4250-7.
14. Ahmed HJ, Frisk A, Månsson J-E, Schweda EKH, Lagergård T. Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies. Infect Immun 1997; 65: 3151-8.
15. Frisk A, Roggen EL, Lagergård T. Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi. 1995; 43: 192-200.
16. Castellazzo A, Shero M, Apicella MA, Spinola SM. Expression of pili by Haemophilus ducreyi. J Infect Dis 1992; 165: (suppl 1): S198-9.
17. Odumeru JA, Wiesman GM, Ronald AR. Role of lipopolysaccharide and complement in the susceptibility of Haemophilus ducreyi to human serum. Infect Immun 1985; 50: 495-9.
18. Lagergård T, Frisk A, Purvén M, Nilsson L-Å. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi. Microb Pathog 1995; 18: 37-51.
19. Alfa MJ, Olson N, Degagne P, et al. Humoral immune response of humans to lipopolysaccharide and outer membrane proteins of Haemophilus ducreyi. J Infect Dis 1993; 167: 1206-10.
20. Lagergård T. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. Microb Pathog 1992; 13: 203-17.
21. Desjardins M, Filion LG, Robertson S, Kobylinski L, Cameron DW. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid. Infect Immun 1996; 64: 1778-88.
22. Alfa MJ, Olsen N, Degagne P, et al. Use of an absorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans. Sex Transm Dis 1992; 19: 309-14.
23. Odumeru JA, Wiseman GM, Ronald AR. Virulence factors of Haemophilus ducreyi. Infect Immun 1984; 43: 607-11.
24. Purvén M, Lagergård T. Haemophilus ducreyi, a cytotoxin producing bacterium. Infect Immun 1992; 60: 1156-62.
25. Ahmed HJ, Borrelli S, Jonasson J, et al. Monoclonal antibodies against Haemophilus ducreyi lipooligosaccharide and their diagnostic usefulness. Eur J Clin Microbiol Infect Dis 1995; 14: 892-8.
26. Borrelli S, Roggen EL, Hendricksen D, et al. Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-Neotetraose. Infect Immun 1995; 63: 2665-73.
27. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-71.